Table 1 Clinical features of hyalinizing clear cell carcinomas of bronchial (a) and salivary (b) origin, and previous reported cases (c)
a. Bronchial gland origin | Â | Â | Â | Â | Â | Â |
|---|---|---|---|---|---|---|
Case | Age | Gender | Smoking (cigarettes per day × years) | Location | Maximum tumor size | Relapse-free survival (months) |
B1 | 52 | F | Non-smoker | Right, segmental bronchus (lower lobe, between B9 and B10) | 33 mm | 181 |
B2 | 35 | F | 15 × 20 | Right, secondary bronchus (lower to middle lobar bronchus) | 28 mm | 79 |
B3 | 56 | F | Non-smoker | Right, secondary bronchus (lower to inferior lobar bronchus) | 33 mm | 12 |
b. Salivary gland origin | Â | Â | Â | Â | Â | Â | Â |
|---|---|---|---|---|---|---|---|
Case | Age | Gender | Smoking (cigarettes per day × years) | Location | Chemoradiation therapy before resection | Maximum tumor size | Relapse-free survival (months) |
S1 | 44 | F | 10 × 15 | Mesopharynx, anterior | 66 Gy + CDDP | 25 mm | 81 |
S2 | 80 | F | Non-smoker | Mesopharynx, anterior | None | 35 mm | 12 |
S3 | 64 | M | 20 × 40 | Buccal mucosa, left | None | 25 mm | 14 |
c. Bronchial gland origin, previous reports | Â | Â | Â | Â | Â | Â | Â |
|---|---|---|---|---|---|---|---|
Case | Reference | Age | Gender | Smoking | Location | Maximum tumor size | Relapse-free survival (months) |
R1 | Garcia JJ, et al [14] | 38 | M | Non-smoker | Right, perihilar mass | 30.3 mm | ND |
R2 | Shah AA, et al [13] | 32 | M | Non-smoker | Left, segmental bronchus | 18 mm | ND |
R3 | Shah AA, et al [13] | 39 | M | Non-smoker | Right, bronchial wall | 26 mm | ND |
R4 | Wang H, et al [15] | 53 | M | Non-smoker | Right, upper lobe | ND | 192 |
R5 | Shahi M, et al [16] | 55 | M | aEx-smoker | Right, middle lobe | 25 mm | 20 |
R6 | Jeffus SK, et al [17] | 54 | F | Ex-light-smokerb | Left, upper lobe | 32 mm | 16 |